| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |